Cargando…

The impact of lung parenchyma attenuation on nodule volumetry in lung cancer screening

BACKGROUND: Recent recommendations for lung nodule management include volumetric analysis using tools that present intrinsic measurement variability, with possible impacts on clinical decisions and patient safety. This study was conducted to evaluate whether changes in the attenuation of the lung pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Penha, Diana, Pinto, Erique, Hochhegger, Bruno, Monaghan, Colin, Marchiori, Edson, Taborda-Barata, Luís, Irion, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233433/
https://www.ncbi.nlm.nih.gov/pubmed/34170410
http://dx.doi.org/10.1186/s13244-021-01027-0
_version_ 1783713850561921024
author Penha, Diana
Pinto, Erique
Hochhegger, Bruno
Monaghan, Colin
Marchiori, Edson
Taborda-Barata, Luís
Irion, Klaus
author_facet Penha, Diana
Pinto, Erique
Hochhegger, Bruno
Monaghan, Colin
Marchiori, Edson
Taborda-Barata, Luís
Irion, Klaus
author_sort Penha, Diana
collection PubMed
description BACKGROUND: Recent recommendations for lung nodule management include volumetric analysis using tools that present intrinsic measurement variability, with possible impacts on clinical decisions and patient safety. This study was conducted to evaluate whether changes in the attenuation of the lung parenchyma adjacent to a nodule affect the performance of nodule segmentation using computed tomography (CT) studies and volumetric tools. METHODS: Two radiologists retrospectively applied two commercially available volumetric tools for the assessment of lung nodules with diameters of 5–8 mm detected by low-dose chest CT during a lung cancer screening program. The radiologists recorded the success and adequacy of nodule segmentation, nodule volume, manually and automatically (or semi-automatically) obtained long- and short-axis measurements, mean attenuation of adjacent lung parenchyma, and presence of interstitial lung abnormalities or disease, emphysema, pleural plaques, and linear atelectasis. Regression analysis was performed to identify predictors of good nodule segmentation using the volumetric tools. Interobserver and intersoftware agreement on good nodule segmentation was assessed using the intraclass correlation coefficient. RESULTS: In total, data on 1265 nodules (mean patient age, 68.3 ± 5.1 years; 70.2% male) were included in the study. In the regression model, attenuation of the adjacent lung parenchyma was highly significant (odds ratio 0.987, p < 0.001), with a large effect size. Interobserver and intersoftware agreement on good segmentation was good, although one software package performed better and measurements differed consistently between software packages. CONCLUSION: For lung nodules with diameters of 5–8 mm, the likelihood of good segmentation declines with increasing attenuation of the adjacent parenchyma.
format Online
Article
Text
id pubmed-8233433
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-82334332021-07-09 The impact of lung parenchyma attenuation on nodule volumetry in lung cancer screening Penha, Diana Pinto, Erique Hochhegger, Bruno Monaghan, Colin Marchiori, Edson Taborda-Barata, Luís Irion, Klaus Insights Imaging Original Article BACKGROUND: Recent recommendations for lung nodule management include volumetric analysis using tools that present intrinsic measurement variability, with possible impacts on clinical decisions and patient safety. This study was conducted to evaluate whether changes in the attenuation of the lung parenchyma adjacent to a nodule affect the performance of nodule segmentation using computed tomography (CT) studies and volumetric tools. METHODS: Two radiologists retrospectively applied two commercially available volumetric tools for the assessment of lung nodules with diameters of 5–8 mm detected by low-dose chest CT during a lung cancer screening program. The radiologists recorded the success and adequacy of nodule segmentation, nodule volume, manually and automatically (or semi-automatically) obtained long- and short-axis measurements, mean attenuation of adjacent lung parenchyma, and presence of interstitial lung abnormalities or disease, emphysema, pleural plaques, and linear atelectasis. Regression analysis was performed to identify predictors of good nodule segmentation using the volumetric tools. Interobserver and intersoftware agreement on good nodule segmentation was assessed using the intraclass correlation coefficient. RESULTS: In total, data on 1265 nodules (mean patient age, 68.3 ± 5.1 years; 70.2% male) were included in the study. In the regression model, attenuation of the adjacent lung parenchyma was highly significant (odds ratio 0.987, p < 0.001), with a large effect size. Interobserver and intersoftware agreement on good segmentation was good, although one software package performed better and measurements differed consistently between software packages. CONCLUSION: For lung nodules with diameters of 5–8 mm, the likelihood of good segmentation declines with increasing attenuation of the adjacent parenchyma. Springer International Publishing 2021-06-25 /pmc/articles/PMC8233433/ /pubmed/34170410 http://dx.doi.org/10.1186/s13244-021-01027-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Penha, Diana
Pinto, Erique
Hochhegger, Bruno
Monaghan, Colin
Marchiori, Edson
Taborda-Barata, Luís
Irion, Klaus
The impact of lung parenchyma attenuation on nodule volumetry in lung cancer screening
title The impact of lung parenchyma attenuation on nodule volumetry in lung cancer screening
title_full The impact of lung parenchyma attenuation on nodule volumetry in lung cancer screening
title_fullStr The impact of lung parenchyma attenuation on nodule volumetry in lung cancer screening
title_full_unstemmed The impact of lung parenchyma attenuation on nodule volumetry in lung cancer screening
title_short The impact of lung parenchyma attenuation on nodule volumetry in lung cancer screening
title_sort impact of lung parenchyma attenuation on nodule volumetry in lung cancer screening
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233433/
https://www.ncbi.nlm.nih.gov/pubmed/34170410
http://dx.doi.org/10.1186/s13244-021-01027-0
work_keys_str_mv AT penhadiana theimpactoflungparenchymaattenuationonnodulevolumetryinlungcancerscreening
AT pintoerique theimpactoflungparenchymaattenuationonnodulevolumetryinlungcancerscreening
AT hochheggerbruno theimpactoflungparenchymaattenuationonnodulevolumetryinlungcancerscreening
AT monaghancolin theimpactoflungparenchymaattenuationonnodulevolumetryinlungcancerscreening
AT marchioriedson theimpactoflungparenchymaattenuationonnodulevolumetryinlungcancerscreening
AT tabordabarataluis theimpactoflungparenchymaattenuationonnodulevolumetryinlungcancerscreening
AT irionklaus theimpactoflungparenchymaattenuationonnodulevolumetryinlungcancerscreening
AT penhadiana impactoflungparenchymaattenuationonnodulevolumetryinlungcancerscreening
AT pintoerique impactoflungparenchymaattenuationonnodulevolumetryinlungcancerscreening
AT hochheggerbruno impactoflungparenchymaattenuationonnodulevolumetryinlungcancerscreening
AT monaghancolin impactoflungparenchymaattenuationonnodulevolumetryinlungcancerscreening
AT marchioriedson impactoflungparenchymaattenuationonnodulevolumetryinlungcancerscreening
AT tabordabarataluis impactoflungparenchymaattenuationonnodulevolumetryinlungcancerscreening
AT irionklaus impactoflungparenchymaattenuationonnodulevolumetryinlungcancerscreening